Indolone compounds useful to treat cognitive impairment

Details for Australian Patent Application No. 2006326665 (hide)

Owner Helicon Therapeutics, Inc.

Inventors Blackburn, Thomas P.

Agent Davies Collison Cave

Pub. Number AU-A-2006326665

PCT Pub. Number WO2007/070362

Priority 60/748,851 09.12.05 US

Filing date 8 December 2006

Wipo publication date 21 June 2007

International Classifications

A61K 31/404 (2006.01)

A61K 31/4045 (2006.01)

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/070362 Priority application(s): WO2007/070362

25 October 2012 Assignment before Grant

  Helicon Therapeutics, Inc. The application has been assigned to Dart NeuroScience (Cayman) Ltd

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326672-Embedded rule engine for rendering text and other applications

2006326662-Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof